WO2018192193A1 - Lamp primer combination for detecting six respiratory viruses and use thereof - Google Patents

Lamp primer combination for detecting six respiratory viruses and use thereof Download PDF

Info

Publication number
WO2018192193A1
WO2018192193A1 PCT/CN2017/105455 CN2017105455W WO2018192193A1 WO 2018192193 A1 WO2018192193 A1 WO 2018192193A1 CN 2017105455 W CN2017105455 W CN 2017105455W WO 2018192193 A1 WO2018192193 A1 WO 2018192193A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
primer set
dna molecule
seq
same function
Prior art date
Application number
PCT/CN2017/105455
Other languages
French (fr)
Chinese (zh)
Inventor
郝荣章
王瑞丽
宋宏彬
孔文
李杨
赵荣涛
孙明璇
贾雷立
邱少富
郭旭东
Original Assignee
中国人民解放军疾病预防控制所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国人民解放军疾病预防控制所 filed Critical 中国人民解放军疾病预防控制所
Publication of WO2018192193A1 publication Critical patent/WO2018192193A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions

Definitions

  • the invention belongs to the field of biotechnology, and particularly relates to a LAMP primer combination for detecting six respiratory viruses and an application thereof.
  • Respiratory infections are classified into upper respiratory tract infections and lower respiratory tract infections. About 90% of upper respiratory tract infections are caused by viruses, and bacterial infections are often secondary to viral infections. The disease can occur in all seasons and at any age, and spreads through droplets, mists, or contaminated utensils containing viruses. Whether it is a lower respiratory tract infection or an upper respiratory tract infection, most of it is caused by a virus called a viral respiratory infection.
  • influenza virus belongs to the Orthomyxoviridae family and is classified into influenza A virus (such as influenza A H1N1 influenza virus, influenza A H3N2 influenza virus, H5N1 avian influenza virus, H7N9 avian influenza virus, etc.), influenza B virus and influenza C virus III.
  • influenza A virus such as influenza A H1N1 influenza virus, influenza A H3N2 influenza virus, H5N1 avian influenza virus, H7N9 avian influenza virus, etc.
  • influenza B virus and influenza C virus III.
  • influenza A virus such as influenza A H1N1 influenza virus, influenza A H3N2 influenza virus, H5N1 avian influenza virus, H7N9 avian influenza virus, etc.
  • influenza B virus influenza C virus III.
  • influenza A virus such as influenza A H1N1 influenza virus, influenza A H3N2 influenza virus, H5N1 avian influenza virus, H7N9 avian influenza virus, etc.
  • influenza B virus and influenza C virus III.
  • influenza A virus such as influenza
  • H5N1 avian influenza virus and H7N9 avian influenza virus have been reported in the world.
  • Adenovirus is a non-encapsulated particle with a diameter of 70-90 nm, which consists of 252 shells arranged in a squamous plane. The linear double-stranded DNA molecule is in the capsid.
  • Human adenovirus (HAdV) is a member of the mammalian adenovirus family of the adenoviridae family. Human adenovirus is one of the most important pathogens causing acute respiratory infections in infants and young children.
  • HAdV-3 human adenovirus type 3
  • HAdV-7 human adenovirus type 7
  • the virus is similar, but more with gastrointestinal symptoms.
  • Adenovirus infections have occurred in many countries and regions around the world. In China, serious outbreaks of adenovirus infection occurred in the last century.
  • Loop-mediated isothermal amplification is a chain of denaturation and automatic cycling of nucleic acids under isothermal conditions using a Bst DNA polymerase with strand displacement activity and waterfall nucleic acid amplification. Replace the nucleic acid amplification reaction.
  • LAMP designs 4 special features for 6 regions of the target sequence

Abstract

The present invention provides a LAMP primer combination for detecting six respiratory viruses and use thereof. The primer combination consists of DNA molecules as shown in sequence 1 to sequence 36, and is used for detecting influenza A H1N1 virus, influenza A H3N2 virus, H5N1 avian influenza virus, H7N9 avian influenza virus, influenza B virus and human adenovirus.

Description

用于检测6种呼吸道病毒的LAMP引物组合及其应用LAMP primer combination for detecting six respiratory viruses and its application 技术领域Technical field
本发明属于生物技术领域,具体涉及用于检测6种呼吸道病毒的LAMP引物组合及其应用。The invention belongs to the field of biotechnology, and particularly relates to a LAMP primer combination for detecting six respiratory viruses and an application thereof.
背景技术Background technique
呼吸道感染分为上呼吸道感染与下呼吸道感染。上呼吸道感染90%左右由病毒引起,细菌感染常继发于病毒感染之后。该病四季、任何年龄均可发病,通过含有病毒的飞沫、雾滴、或经污染的用具进行传播。无论是下呼吸道感染还是上呼吸道感染,绝大部分是由病毒引起的,称为病毒性呼吸道感染。Respiratory infections are classified into upper respiratory tract infections and lower respiratory tract infections. About 90% of upper respiratory tract infections are caused by viruses, and bacterial infections are often secondary to viral infections. The disease can occur in all seasons and at any age, and spreads through droplets, mists, or contaminated utensils containing viruses. Whether it is a lower respiratory tract infection or an upper respiratory tract infection, most of it is caused by a virus called a viral respiratory infection.
流感病毒属于正黏病毒科,分为甲型流感病毒(如甲型H1N1流感病毒、甲型H3N2流感病毒、H5N1禽流感病毒、H7N9禽流感病毒等)、乙型流感病毒和丙型流感病毒三种。流感病毒是一种严重威胁人类健康的病原体,能感染广泛宿主,每年季节性的流行造成全球约6亿人感染,并导致25-50万人死亡,其中造成感染和死亡的主要是甲型流感病毒。在过去的100多年里,流感病毒至少在全球范围内引发过四次大流行,这几次大流行都是因为动物源性的流感病毒跨越宿主屏障感染人所导致。近年在全球时见报道的主要是H5N1禽流感病毒和H7N9禽流感病毒,比如1997年在香港爆发的H5N1禽流感直接感染人并导致死亡;2013年在上海、安徽等地爆发的H7N9禽流感造成300多人感染,50多人死亡。这些事件证明流感病毒不但造成巨大经济损失,同时还可能跨越宿主屏障直接感染人类,严重威胁人类公共卫生安全。The influenza virus belongs to the Orthomyxoviridae family and is classified into influenza A virus (such as influenza A H1N1 influenza virus, influenza A H3N2 influenza virus, H5N1 avian influenza virus, H7N9 avian influenza virus, etc.), influenza B virus and influenza C virus III. Kind. Influenza virus is a serious threat to human health and can infect a wide range of hosts. The annual seasonal epidemic causes about 600 million infections worldwide and causes 250,000-500,000 deaths. The main cause of infection and death is influenza A. virus. In the past 100 years, the flu virus has caused at least four pandemics worldwide, all of which are caused by animal-borne influenza viruses that infect people across the host barrier. In recent years, H5N1 avian influenza virus and H7N9 avian influenza virus have been reported in the world. For example, H5N1 avian influenza outbreak in Hong Kong in 1997 directly infected people and caused death. In 2013, H7N9 avian influenza broke out in Shanghai and Anhui. More than 300 people were infected and more than 50 died. These events prove that the flu virus not only causes huge economic losses, but also directly infects humans across the host barrier, posing a serious threat to human public health security.
腺病毒是一种没有包膜的直径为70~90nm的颗粒,由252个壳粒呈廿面体排列构成。衣壳里是线状双链DNA分子。人腺病毒(Human adenovirus,HAdV)为腺病毒科的哺乳动物腺病毒属成员之一,人腺病毒是引起婴幼儿急性呼吸道感染等多种疾病的重要病原体之一。导致急性呼吸道感染的主要流行株为HAdV-3(人腺病毒3型)和HAdV-7(人腺病毒7型),也可以引起其他系统的疾病,所致疾病的临床表现与其它呼吸道病毒相关病毒相似,但多伴消化道症状。全球很多国家和地区曾发生腺病毒感染暴发,我国曾于上世纪发生严重的腺病毒感染暴发流行。Adenovirus is a non-encapsulated particle with a diameter of 70-90 nm, which consists of 252 shells arranged in a squamous plane. The linear double-stranded DNA molecule is in the capsid. Human adenovirus (HAdV) is a member of the mammalian adenovirus family of the adenoviridae family. Human adenovirus is one of the most important pathogens causing acute respiratory infections in infants and young children. The main epidemic strains causing acute respiratory infections are HAdV-3 (human adenovirus type 3) and HAdV-7 (human adenovirus type 7), which can also cause diseases in other systems, and the clinical manifestations of the disease are related to other respiratory viruses. The virus is similar, but more with gastrointestinal symptoms. Adenovirus infections have occurred in many countries and regions around the world. In China, serious outbreaks of adenovirus infection occurred in the last century.
呼吸道病毒的流行会给整个人类社会带来重大安全问题。开展呼吸道病毒的快速检测,对于重大传染病疫情和生物恐怖的防控具有重要意义。发展针对呼吸道病毒多种病原体的快速检测技术是及时发现传染源,实施及时有效隔离和控制传染源的关键。近年来,分子诊断方法(如聚合酶链式反应)被用于呼吸道病毒的检测,它能够准确地鉴定目标序列,但是它需要有热循环系统的元件,这通常依赖于大型仪器且价格昂贵,不利于开展快速检测。The prevalence of respiratory viruses can pose major security problems for the entire human society. The rapid detection of respiratory viruses is of great significance for the prevention and control of major infectious diseases and bioterrorism. The rapid detection technology for the development of multiple pathogens of respiratory viruses is the key to timely discovering the source of infection and implementing timely and effective isolation and control of infectious sources. In recent years, molecular diagnostic methods (such as polymerase chain reaction) have been used for the detection of respiratory viruses, which can accurately identify target sequences, but it requires components of thermal cycling systems, which are often dependent on large instruments and are expensive. Not conducive to rapid detection.
环介导等温扩增法(loop-mediated isothermal amplification,LAMP)是利用一种具有链置换活性和瀑布式核酸扩增功能的Bst DNA聚合酶,在等温条件下进行核酸的变性和自动循环的链置换核酸扩增反应。LAMP针对靶序列的6个区域设计4条特 Loop-mediated isothermal amplification (LAMP) is a chain of denaturation and automatic cycling of nucleic acids under isothermal conditions using a Bst DNA polymerase with strand displacement activity and waterfall nucleic acid amplification. Replace the nucleic acid amplification reaction. LAMP designs 4 special features for 6 regions of the target sequence

Claims (1)

  1. 异引物,利用具备链置换功能的DNA聚合酶在恒定温度下不断复制扩增DNA。为了提高反应效率,可在反应体系中添加两条环引物,使之分别与茎环结构结合,启动链置换合成,循环复制。LAMP具有简便、快速、灵敏、特异的优势,尤其适合在基层开展LAMP试剂盒的应用推广。LAMP技术中,引物是决定检测结果灵敏度和特异性的关键因素。A heterologous primer that continuously replicates amplified DNA at a constant temperature using a DNA polymerase having a strand displacement function. In order to improve the reaction efficiency, two loop primers may be added to the reaction system to bind to the stem-loop structure, start strand displacement synthesis, and cyclic replication. LAMP has the advantages of simplicity, rapidity, sensitivity and specificity, and is especially suitable for the application of LAMP kits in the grassroots. In LAMP technology, primers are a key factor in determining the sensitivity and specificity of the test results.
    发明公开Invention disclosure
    本发明所要解决的技术问题是如何检测甲型H1N1流感病毒、甲型H3N2流感病毒、H5N1禽流感病毒、H7N9禽流感病毒、乙型流感病毒和人腺病毒。The technical problem to be solved by the present invention is how to detect influenza A H1N1 virus, influenza A H3N2 virus, H5N1 avian influenza virus, H7N9 avian influenza virus, influenza B virus and human adenovirus.
    为解决上述技术问题,本发明首先提供了一种引物组合,可为如下(a1)或(a2)或(a3):In order to solve the above technical problems, the present invention first provides a primer combination which may be as follows (a1) or (a2) or (a3):
    (a1)由引物组Ⅰ、引物组Ⅱ、引物组Ⅲ、引物组Ⅳ、引物组Ⅴ和引物组Ⅵ组成;(a1) consisting of primer set I, primer set II, primer set III, primer set IV, primer set V, and primer set VI;
    (a2)由所述引物组Ⅰ、所述引物组Ⅱ、所述引物组Ⅲ、所述引物组Ⅳ、所述引物组Ⅴ和所述引物组Ⅵ中的任意两个、任意三个、任意四个或任意五个组成;(a2) any two, any three, any of the primer set I, the primer set II, the primer set III, the primer set IV, the primer set V, and the primer set VI Four or any five components;
    (a3)所述引物组Ⅰ、所述引物组Ⅱ、所述引物组Ⅲ、所述引物组Ⅳ、所述引物组Ⅴ或所述引物组Ⅵ。(a3) the primer set I, the primer set II, the primer set III, the primer set IV, the primer set V or the primer set VI.
    所述引物组Ⅰ可由H1N1-F3、H1N1-B3、H1N1-FIP、H1N1-BIP、H1N1-LF和H1N1-LB组成;所述H1N1-F3可为如下(b1)或(b2):(b1)序列表的序列1所示的单链DNA分子;(b2)将序列1经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列1具有相同功能的DNA分子;所述H1N1-B3可为如下(b3)或(b4):(b3)序列表的序列2所示的单链DNA分子;(b4)将序列2经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列2具有相同功能的DNA分子;所述H1N1-FIP可为如下(b5)或(b6):(b5)序列表的序列3所示的单链DNA分子;(b6)将序列3经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列3具有相同功能的DNA分子;所述H1N1-BIP可为如下(b7)或(b8):(b7)序列表的序列4所示的单链DNA分子;(b8)将序列4经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列4具有相同功能的DNA分子;所述H1N1-LF可为如下(b9)或(b10):(b9)序列表的序列5所示的单链DNA分子;(b10)将序列5经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列5具有相同功能的DNA分子;所述H1N1-LB可为如下(b11)或(b12):(b11)序列表的序列6所示的单链DNA分子;(b12)将序列6经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列6具有相同功能的DNA分子。The primer set I may be composed of H1N1-F3, H1N1-B3, H1N1-FIP, H1N1-BIP, H1N1-LF and H1N1-LB; the H1N1-F3 may be as follows (b1) or (b2): (b1) a single-stranded DNA molecule as shown in SEQ ID NO: 1 of the Sequence Listing; (b2) a DNA molecule having one or more nucleotide substitutions and/or deletions and/or additions and having the same function as Sequence 1; H1N1-B3 may be a single-stranded DNA molecule as shown in SEQ ID NO: 2 of the sequence listing (b3) or (b4): (b3); (b4) substitution and/or deletion of sequence 2 by one or several nucleotides And/or a DNA molecule which has the same function as that of the sequence 2; the H1N1-FIP may be a single-stranded DNA molecule represented by the sequence 3 of the sequence table (b5) or (b6): (b5); (b6) Sequence 3 is subjected to one or several nucleotide substitutions and/or deletions and/or additions of DNA molecules having the same function as Sequence 3; said H1N1-BIP may be as follows (b7) or (b8): (b7 a single-stranded DNA molecule as shown in SEQ ID NO: 4 of the Sequence Listing; (b8) a DNA molecule having a sequence 4 having a substitution and/or deletion and/or addition of one or several nucleotides and having the same function as that of SEQ ID NO:4; H1N1-LF can be as follows (b9) or (b10): (b9) sequence a single-stranded DNA molecule as shown in SEQ ID NO: 5; (b10) a DNA molecule which has undergone substitution and/or deletion and/or addition of sequence 5 with one or several nucleotides and which has the same function as that of SEQ ID NO: 5; -LB may be a single-stranded DNA molecule as shown in SEQ ID NO: 6 of the sequence listing (b11) or (b12): (b11); (b12) a substitution and/or deletion of sequence 6 by one or several nucleotides / or a DNA molecule added and having the same function as that of SEQ ID NO: 6.
    所述引物组Ⅱ可由H3N2-F3、H3N2-B3、H3N2-FIP、H3N2-BIP、H3N2-LF和H3N2-LB组成;所述H3N2-F3可为如下(c1)或(c2):(c1)序列表的序列7所示的单链DNA分子;(c2)将序列7经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列7具有相同功能的DNA分子;所述H3N2-B3可为如下(c3)或(c4):(c3)序列表的序列8所示的单链DNA分子;(c4)将序列8经过一个或几个核苷酸的取代和/或缺失和/或添加且与序列8具有相同功能的DNA分子;所述H3N2-FIP可为如下(c5)或(c6):(c5)序列表的序列9所示的单链DNA分子;(c6)将序列9经过一个或几个核苷酸 The primer set II may be composed of H3N2-F3, H3N2-B3, H3N2-FIP, H3N2-BIP, H3N2-LF and H3N2-LB; the H3N2-F3 may be as follows (c1) or (c2): (c1) a single-stranded DNA molecule as shown in SEQ ID NO: 7; (c2) a DNA molecule having sequence 7 substituted and/or deleted and/or added and having the same function as SEQ ID NO: 7; H3N2-B3 may be a single-stranded DNA molecule as shown in SEQ ID NO: 8 of the sequence listing (c3) or (c4): (c3); (c4) substitution and/or deletion of sequence 8 by one or several nucleotides And/or a DNA molecule having the same function as that of the sequence 8; the H3N2-FIP may be a single-stranded DNA molecule represented by the sequence 9 of the sequence listing (c5) or (c6): (c5); (c6) Pass sequence 9 through one or several nucleotides
PCT/CN2017/105455 2017-04-18 2017-10-10 Lamp primer combination for detecting six respiratory viruses and use thereof WO2018192193A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710251770.7A CN106884012B (en) 2017-04-18 2017-04-18 L AMP primer combination for detecting 6 respiratory viruses and application thereof
CN201710251770.7 2017-04-18

Publications (1)

Publication Number Publication Date
WO2018192193A1 true WO2018192193A1 (en) 2018-10-25

Family

ID=59182918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/105455 WO2018192193A1 (en) 2017-04-18 2017-10-10 Lamp primer combination for detecting six respiratory viruses and use thereof

Country Status (2)

Country Link
CN (1) CN106884012B (en)
WO (1) WO2018192193A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106884012B (en) * 2017-04-18 2020-07-28 中国人民解放军疾病预防控制所 L AMP primer combination for detecting 6 respiratory viruses and application thereof
CN108642212A (en) * 2018-07-02 2018-10-12 上海交通大学医学院附属上海儿童医学中心 Ring mediated isothermal amplification detects the kit and method of A type H3N2 influenza viruses
CN109504803A (en) * 2018-11-22 2019-03-22 李越希 A kind of RPA method, its primer special and probe and purposes detecting 7 type adenovirus hominis
CN111172324A (en) * 2020-02-17 2020-05-19 深圳麦科田生物医疗技术有限公司 Probe, primer, kit and detection method for detecting viruses A and B based on double loop-mediated isothermal amplification technology
US11761031B2 (en) * 2020-05-28 2023-09-19 The Hong Kong University Of Science And Technology Method for real time monitoring of nucleic acid amplicons mediated by loop oligonucleotide probes
CN113136454B (en) * 2021-04-15 2022-07-12 厦门健康工程与创新研究院 Multiple LAMP primer combination for detecting multiple influenza viruses and application thereof
CN113073151A (en) * 2021-05-12 2021-07-06 广州普世利华科技有限公司 Primer probe composition for detecting adenovirus HAdV by using enzyme digestion probe report system and kit thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015048098A1 (en) * 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
CN106884012A (en) * 2017-04-18 2017-06-23 中国人民解放军疾病预防控制所 LAMP primer composition and its application for 6 kinds of Respiroviruses of detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104278024B (en) * 2013-07-05 2016-12-28 中国人民解放军军事医学科学院微生物流行病研究所 For identifying Primer composition and their application of human adenovirus 55 type

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015048098A1 (en) * 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
CN106884012A (en) * 2017-04-18 2017-06-23 中国人民解放军疾病预防控制所 LAMP primer composition and its application for 6 kinds of Respiroviruses of detection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIU, FANG ET AL.: "Surveillance Analysis of Respiratory Viruses of Entry Pilgrims in Gansu Port During 2014", CHINESE JOURNAL OF FRONTIER HEALTH AND QUARANTINE, vol. 38, no. 3, 30 June 2015 (2015-06-30) *

Also Published As

Publication number Publication date
CN106884012B (en) 2020-07-28
CN106884012A (en) 2017-06-23

Similar Documents

Publication Publication Date Title
WO2018192193A1 (en) Lamp primer combination for detecting six respiratory viruses and use thereof
Imamura et al. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections
Ni et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008–2011
Jartti et al. New respiratory viral infections
Pavia What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?
Piralla et al. Phylogenetic characterization of enterovirus 68 strains in patients with respiratory syndromes in Italy
Jartti et al. New respiratory viruses and the elderly
Guo et al. Detection of three human adenovirus species in adults with acute respiratory infection in China
Zhang et al. Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination
Kunz et al. The role of adenovirus in respiratory tract infections
To et al. Unique reassortant of influenza A (H7N9) virus associated with severe disease emerging in Hong Kong
Tao et al. Influenza A virus coinfection through transmission can support high levels of reassortment
Zou et al. Adenovirus infection in children hospitalized with pneumonia in Guangzhou, China
CN105671204B (en) NDV/H9-AIV/IBV triple fluorescent PCR detection reagent
Song et al. Rapid detection of duck hepatitis virus type-1 by reverse transcription loop-mediated isothermal amplification
Batéjat et al. Heat inactivation of monkeypox virus
Sivanesan et al. Consolidating the potency of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) in viral diagnosis: Extrapolating its applicability for COVID diagnosis?
Yang et al. Molecular characterization and antigenic analysis of reassortant H9N2 subtype avian influenza viruses in Eastern China in 2016
Papillard‐Marechal et al. Monitoring epidemic viral respiratory infections using one‐step real‐time triplex RT‐PCR targeting influenza A and B viruses and respiratory syncytial virus
Chang et al. Avian influenza viruses (AIVs) H9N2 are in the course of reassorting into novel AIVs
Apostoli et al. Human metapneumovirus‐associated hospital admissions over five consecutive epidemic seasons: evidence for alternating circulation of different genotypes
Renois et al. Enteroviruses as major cause of microbiologically unexplained acute respiratory tract infections in hospitalized pediatric patients
Chen et al. Is avian influenza A (H7N9) virus staggering its way to humans?
Guofeng et al. Detections of major respiratory pathogens in pneumonia patients in early phase of COVID-19 epidemic in Tongzhou, Beijing
Jin et al. Prevalence and clinical characteristics of human CoV-HKU1 in children with acute respiratory tract infections in China

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17906602

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17906602

Country of ref document: EP

Kind code of ref document: A1